Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past--issues for the future.

[1]  J. Rodés,et al.  Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial , 2000 .

[2]  T. Therneau,et al.  Ursodeoxycholic acid for primary biliary cirrhosis , 2000, The Lancet.

[3]  A. Burroughs,et al.  Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis , 1999, The Lancet.

[4]  Y. Chrétien,et al.  Ten‐year survival in ursodeoxycholic acid–treated patients with primary biliary cirrhosis , 1999, Hepatology.

[5]  T. Therneau,et al.  Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial. , 1999, Journal of hepatology.

[6]  T. Therneau,et al.  Long‐term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis , 1999, Hepatology.

[7]  K. Lindor,et al.  Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis , 1999, Hepatology.

[8]  J. Boyer,et al.  Ursodeoxycholic acid in cholestasis: Potential mechanisms of action and therapeutic applications , 1998, Hepatology.

[9]  G. V. B. Henegouwen,et al.  A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg , 1998, Alimentary pharmacology & therapeutics.

[10]  C. Steer,et al.  A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. , 1998, The Journal of clinical investigation.

[11]  E. Dickson,et al.  Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. , 1997, Gastroenterology.

[12]  G. Grégoire,et al.  Discrepancies between meta-analyses and subsequent large randomized, controlled trials. , 1997, The New England journal of medicine.

[13]  K. Einarsson,et al.  Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study. , 1997, Scandinavian journal of gastroenterology.

[14]  G. Tytgat,et al.  Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. , 1996, Gastroenterology.

[15]  T. Therneau,et al.  Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. , 1996, Gastroenterology.

[16]  A. West,et al.  A randomized, double‐blind, placebo‐controlled trial of ursodeoxycholic acid in primary biliary cirrhosis , 1993, Hepatology.

[17]  B. Balkau,et al.  Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. , 1994, The New England journal of medicine.

[18]  U. Steinbrecher,et al.  The canadian multicenter double‐blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis , 1994, Hepatology.

[19]  E. Dickson,et al.  Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. , 1994, Gastroenterology.

[20]  E. Christensen,et al.  Ursodeoxycholic Acid for Primary Biliary Cirrhosis? , 1987, The Cochrane database of systematic reviews.

[21]  F. Schaffner,et al.  Serum bilirubin: a prognostic factor in primary biliary cirrhosis. , 1979, Gut.